SHARE
Urology Imaging Equipment Market

Urology Imaging Equipment - Global Market Outlook (2019-2027)

4.2 (45 reviews)
Published: June 2020 ID: SMRC19344
4.2 (45 reviews)
Published: June 2020 ID: SMRC19344

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Urology Imaging Equipment market is accounted for $1.38 billion in 2019 and is expected to reach $2.18 billion by 2027 growing at a CAGR of 5.9% during the forecast period. Some of the key factors propelling the market growth include increasing binge eating and consumption of junk foods, neglect towards regular exercise, rising levels of stress, adoption of multimodality imaging technologies, and rise in prevalence of urology diseases. However, product recall and high cost are likely to restraint the market.

By type, the x-ray/fluoroscopy imaging systems segment is projected to grow at the significant rate during the forecast period. Advanced systems including multimodality integration technologies are anticipated to drive the segment. Among urological disorders in humans, prevalence of kidney stone is increasing. According to an article published in the advances in urology, kidney stone affected approximately 12% of the world’s population and it is most common in men within the age of 20 to 49 years.

On the basis of geography, North America region is expected to have considerable market growth during the forecast period, due to the presence of key players, large number of research activities, and highly structured healthcare industry. Moreover, strategies adopted by key players such as product approval & launch and rise in number of patients with urological diseases are anticipated to fuel the growth of the urology imaging equipment market in the region. The US is anticipated to be the most attractive market for urology imaging equipment, with high attractiveness index.

Some of the key players in urology imaging equipment market include Bristol-Myers Squibb Company, Johnson & Johnson, Boehringer Ingelheim International GmbH, Novartis AG, Eisai Co., Ltd., Bayer AG, AstraZeneca plc, Pfizer, Inc., GE Healthcare (General Electric Company), F. Hoffmann-La Roche Ltd, Stryker, Olympus Corporation, Siemens Healthineers, Richard Wolf GmbH, Boston Scientific Corporation, KARL STORZ, CANON MEDICAL SYSTEMS CORPORATION, Koninklijke Philips N.V., and Guerbet.

Types Covered:
• Receptor Tyrosine Kinase Inhibitors
• Non-receptor Tyrosine Kinase Inhibitors
• Serine/Threonine Kinase Inhibitors
• RHO Kinase Inhibitors
• Multikinase inhibitors
• Protein Kinase C Inhibitors
• X-ray/Fluoroscopy Imaging Systems
• Endovision Systems
• Urology Operating Tables
• Ultrasound Systems

Distribution Channels Covered:
• Independent Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Applications Covered:
• Inflammatory Diseases
• Oncology
• Diagnostics
• Interventional

End Users Covered:
• Ambulatory Surgical Centers
• Hospitals
• Specialty Clinics

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain
o Rest of Europe      
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary    
     
2 Preface    

 2.1 Abstract   
 2.2 Stake Holders   
 2.3 Research Scope   
 2.4 Research Methodology   
  2.4.1 Data Mining  
  2.4.2 Data Analysis  
  2.4.3 Data Validation  
  2.4.4 Research Approach  
 2.5 Research Sources   
  2.5.1 Primary Research Sources  
  2.5.2 Secondary Research Sources  
  2.5.3 Assumptions  
     
3 Market Trend Analysis    
 3.1 Introduction   
 3.2 Drivers   
 3.3 Restraints   
 3.4 Opportunities   
 3.5 Threats   
 3.6 Application Analysis   
 3.7 End User Analysis   
 3.8 Emerging Markets   
 3.9 Impact of Covid-19   
     
4 Porters Five Force Analysis    
 4.1 Bargaining power of suppliers   
 4.2 Bargaining power of buyers   
 4.3 Threat of substitutes   
 4.4 Threat of new entrants   
 4.5 Competitive rivalry   
      
5 Global Urology Imaging Equipment Market, By Type    
 5.1 Introduction   
 5.2 Receptor Tyrosine Kinase Inhibitors   
  5.2.1 Platelet-derived Growth Factor Receptors (PDGFR)   
  5.2.2 Vascular Endothelial Growth Factor Receptor (VEGFR)  
  5.2.3 Anaplastic lymphoma kinase (ALK)  
  5.2.4 Human Epidermal Growth Factor Receptor 2 (HER2)  
  5.2.5 Estimated Glomerular Filtration Rate (EGFR)  
 5.3 Non-receptor Tyrosine Kinase Inhibitors   
  5.3.1 BCR-ABL  
  5.3.2 Mesenchymal Epithelial Transition Growth Factor (c-MET)  
  5.3.3 Bruton’s Tyrosine Kinase (BTK) Inhibitors  
  5.3.4 Spleen Tyrosine Kinase (SYK) Inhibitors  
  5.3.5 Janus Kinase (JAK) Inhibitor  
 5.4 Serine/Threonine Kinase Inhibitors   
 5.5 RHO Kinase Inhibitors   
 5.6 Multikinase inhibitors   
 5.7 Protein Kinase C Inhibitors   
 5.8 X-ray/Fluoroscopy Imaging Systems   
 5.9 Endovision Systems   
 5.10 Urology Operating Tables   
 5.11 Ultrasound Systems   
     
6 Global Urology Imaging Equipment Market, By Distribution Channel    
 6.1 Introduction   
 6.2 Independent Pharmacies   
 6.3 Hospital Pharmacies   
 6.4 Online Pharmacies   
     
7 Global Urology Imaging Equipment Market, By Application    
 7.1 Introduction   
 7.2 Inflammatory Diseases   
 7.3 Oncology   
  7.3.1 Renal Cell Cancer  
  7.3.2 Lung Cancer  
  7.3.3 Breast Cancer  
 7.4 Diagnostics   
 7.5 Interventional   
     
8 Global Urology Imaging Equipment Market, By End User    
 8.1 Introduction   
 8.2 Ambulatory Surgical Centers   
 8.3 Hospitals   
 8.4 Specialty Clinics   
     
9 Global Urology Imaging Equipment Market, By Geography    

 9.1 Introduction   
 9.2 North America   
  9.2.1 US  
  9.2.2 Canada  
  9.2.3 Mexico  
 9.3 Europe   
  9.3.1 Germany  
  9.3.2 UK  
  9.3.3 Italy  
  9.3.4 France  
  9.3.5 Spain  
  9.3.6 Rest of Europe  
 9.4 Asia Pacific   
  9.4.1 Japan  
  9.4.2 China  
  9.4.3 India  
  9.4.4 Australia  
  9.4.5 New Zealand  
  9.4.6 South Korea  
  9.4.7 Rest of Asia Pacific  
 9.5 South America   
  9.5.1 Argentina  
  9.5.2 Brazil  
  9.5.3 Chile  
  9.5.4 Rest of South America  
 9.6 Middle East & Africa   
  9.6.1 Saudi Arabia  
  9.6.2 UAE  
  9.6.3 Qatar  
  9.6.4 South Africa  
  9.6.5 Rest of Middle East & Africa  
     
10 Key Developments    
 10.1 Agreements, Partnerships, Collaborations and Joint Ventures   
 10.2 Acquisitions & Mergers   
 10.3 New Product Launch   
 10.4 Expansions   
 10.5 Other Key Strategies   
     
11 Company Profiling     
 11.1 Bristol-Myers Squibb Company   
 11.2 Johnson & Johnson   
 11.3 Boehringer Ingelheim International GmbH   
 11.4 Novartis AG   
 11.5 Eisai Co., Ltd.   
 11.6 Bayer AG   
 11.7 AstraZeneca plc   
 11.8 Pfizer, Inc.   
 11.9 GE Healthcare (General Electric Company)   
 11.10 F. Hoffmann-La Roche Ltd   
 11.11 Stryker   
 11.12 Olympus Corporation   
 11.13 Siemens Healthineers   
 11.14 Richard Wolf GmbH   
 11.15 Boston Scientific Corporation   
 11.16 KARL STORZ   
 11.17 CANON MEDICAL SYSTEMS CORPORATION   
 11.18 Koninklijke Philips N.V.   
 11.19 Guerbet  


List of Tables     
1 Global Urology Imaging Equipment Market Outlook, By Region (2018-2027) ($MN)    
2 Global Urology Imaging Equipment Market Outlook, By Type (2018-2027) ($MN)    
3 Global Urology Imaging Equipment Market Outlook, By Receptor Tyrosine Kinase Inhibitors (2018-2027) ($MN)    
4 Global Urology Imaging Equipment Market Outlook, By Platelet-derived Growth Factor Receptors (PDGFR) (2018-2027) ($MN)    
5 Global Urology Imaging Equipment Market Outlook, By Vascular Endothelial Growth Factor Receptor (VEGFR) (2018-2027) ($MN)    
6 Global Urology Imaging Equipment Market Outlook, By Anaplastic lymphoma kinase (ALK) (2018-2027) ($MN)    
7 Global Urology Imaging Equipment Market Outlook, By Human Epidermal Growth Factor Receptor 2 (HER2) (2018-2027) ($MN)    
8 Global Urology Imaging Equipment Market Outlook, By Estimated Glomerular Filtration Rate (EGFR) (2018-2027) ($MN)    
9 Global Urology Imaging Equipment Market Outlook, By Non-receptor Tyrosine Kinase Inhibitors (2018-2027) ($MN)    
10 Global Urology Imaging Equipment Market Outlook, By BCR-ABL (2018-2027) ($MN)    
11 Global Urology Imaging Equipment Market Outlook, By Mesenchymal Epithelial Transition Growth Factor (c-MET) (2018-2027) ($MN)    
12 Global Urology Imaging Equipment Market Outlook, By Bruton’s Tyrosine Kinase (BTK) Inhibitors (2018-2027) ($MN)    
13 Global Urology Imaging Equipment Market Outlook, By Spleen Tyrosine Kinase (SYK) Inhibitors (2018-2027) ($MN)    
14 Global Urology Imaging Equipment Market Outlook, By Janus Kinase (JAK) Inhibitor (2018-2027) ($MN)    
15 Global Urology Imaging Equipment Market Outlook, By Serine/Threonine Kinase Inhibitors (2018-2027) ($MN)    
16 Global Urology Imaging Equipment Market Outlook, By RHO Kinase Inhibitors (2018-2027) ($MN)    
17 Global Urology Imaging Equipment Market Outlook, By Multikinase inhibitors (2018-2027) ($MN)    
18 Global Urology Imaging Equipment Market Outlook, By Protein Kinase C Inhibitors (2018-2027) ($MN)    
19 Global Urology Imaging Equipment Market Outlook, By X-ray/Fluoroscopy Imaging Systems (2018-2027) ($MN)    
20 Global Urology Imaging Equipment Market Outlook, By Endovision Systems (2018-2027) ($MN)    
21 Global Urology Imaging Equipment Market Outlook, By Urology Operating Tables (2018-2027) ($MN)    
22 Global Urology Imaging Equipment Market Outlook, By Ultrasound Systems (2018-2027) ($MN)    
23 Global Urology Imaging Equipment Market Outlook, By Distribution Channel (2018-2027) ($MN)    
24 Global Urology Imaging Equipment Market Outlook, By Independent Pharmacies (2018-2027) ($MN)    
25 Global Urology Imaging Equipment Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)    
26 Global Urology Imaging Equipment Market Outlook, By Online Pharmacies (2018-2027) ($MN)    
27 Global Urology Imaging Equipment Market Outlook, By Application (2018-2027) ($MN)    
28 Global Urology Imaging Equipment Market Outlook, By Inflammatory Diseases (2018-2027) ($MN)    
29 Global Urology Imaging Equipment Market Outlook, By Oncology (2018-2027) ($MN)    
30 Global Urology Imaging Equipment Market Outlook, By Renal Cell Cancer (2018-2027) ($MN)    
31 Global Urology Imaging Equipment Market Outlook, By Lung Cancer (2018-2027) ($MN)    
32 Global Urology Imaging Equipment Market Outlook, By Breast Cancer (2018-2027) ($MN)    
33 Global Urology Imaging Equipment Market Outlook, By Diagnostics (2018-2027) ($MN)    
34 Global Urology Imaging Equipment Market Outlook, By Interventional (2018-2027) ($MN)    
35 Global Urology Imaging Equipment Market Outlook, By End User (2018-2027) ($MN)    
36 Global Urology Imaging Equipment Market Outlook, By Ambulatory Surgical Centers (2018-2027) ($MN)    
37 Global Urology Imaging Equipment Market Outlook, By Hospitals (2018-2027) ($MN)    
38 Global Urology Imaging Equipment Market Outlook, By Specialty Clinics (2018-2027) ($MN)    
     
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.     

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials